biotech
biotech Articles
Verastem saw perhaps the biggest gain in the market Wednesday after the company announced positive late-stage results.
Published:
Last Updated:
Sarepta Therapeutics saw its shares make a handy gain on Wednesday after the firm announced muscle biopsy results from its mid-stage study for the treatment of Duchenne muscular dystrophy.
Published:
Last Updated:
Insmed has filed with the SEC for a secondary offering. This follows a surge in the share price following positive late-stage results from its clinical study in the treatment of nontuberculous...
Published:
Last Updated:
Cellectis shares tumbled early on Tuesday after the firm announced that a couple of its early-stage studies were put on hold by the FDA.
Published:
Last Updated:
Insmed saw its shares more than double early on Tuesday after the firm released late-stage results from its clinical study in the treatment of nontuberculous mycobacteria lung disease.
Published:
Last Updated:
Otonomy saw its shares crater after the firm announced results for its Averts-1 late-stage trial of Otividex in patients with Ménière’s disease.
Published:
Last Updated:
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
Published:
Last Updated:
Acorda Therapeutics saw its shares get crushed early on Tuesday after the firm received a Refusal to File letter from the FDA in regards to its New Drug Application for Inbrija.
Published:
Last Updated:
Gilead Sciences shares have been in a holding pattern for a while. Analysts have said that the firm needs to make a move to shake this situation, otherwise this could turn into something worse.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Ultragenyx Pharmaceutical just hit a 52-week low and analysts have slashed and burned their price target expectations. This is after a late-stage trial did not live up to expectations.
Published:
Last Updated:
Intra-Cellular Therapies saw its shares make an incredible gain early on Wednesday after the FDA gave a positive regulatory update on the firm’s schizophrenia program.
Published:
Last Updated:
Gene therapy company Krystal Biotech has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
The quiet period for Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) is over after its initial public offering. The Westlake Village, California-based company recently sold just 4,983,333 shares of...
Published:
Last Updated:
Coherus Biosciences, Inc. (NASDAQ: CHRS) watched its shares jump on Monday after the company announced that it plans to raise up to $150 million in a two tranche private placement. A Singapore...
Published:
Last Updated: